Bone marrow (BM)-derived CD45 cells in conjunction with long non-coding RNA (GAS5) mitigate liver cirrhosis by suppressing the activation of hepatic stellate cells via regulating the signaling pathways of miR-21/MMP-9 and miR-222/p27

Xing Lu,Ying Xiang,Juan Tian,Ming Jiang,Wei Liu,Fan Wu,Lijuan Yu,Guohui Feng,Shan Zhong,Hua Wen

DOI: https://doi.org/10.1016/J.OMTN.2020.10.024

2020-01-01

Abstract:Abstract Bone marrow (BM)-derived CD45 cells (BM45) were demonstrated to exhibit an improved antifibrotic effect on the treatment of CCL4-induced liver fibrosis by significantly increasing the level of MMP-9. In this study, we aimed to validate the therapeutic effect of BM45 on the treatment of liver cirrhosis, and further investigate the molecular mechanism underlying the effect of GAS5 on BM45. Accordingly, GAS5 significantly suppressed miR-222 and miR-21 expression but enhanced p27 and MMP-9 expression in HepG2 and LX2 cells. And GAS5 obstructed TGF-β induced dysregulation of miR-222, p27 and α-SMA in mice. GAS showed a considerable potential to enhance the capability of BM45 in restoring the normal expression of CCL4, miR-222, miR-21, MMP-9, p27 and α-SMA that was dysregulated by ALT, albumin, and fibrosis. In summary, our study validated the regulatory relationship between miR-21 and MMP-9, as well as between miR-222 and p27. The over-expression of GAS5 up-regulated the expression of MMP-9 and p27 via respectively reducing the miR-222 and miR-21 expression, resulting in higher BM45-induced activation of HSCs. Accordingly, same results were obtained in an animal model, indicating that GAS5 may exert a positive effect on the treatment of BM45 of liver cirrhosis.